Pharmaceuticals and feed additives

Huvepharma® is focused on bringing human health and animal health and nutrition products to market.

View all products

In-house production

Mastering the complete production cycle in-house; from strain to shelf.

More about production

Global reach

With our global organization, we aim to reach and improve the performance of every animal in the production chain.

Find your local contact

Customer service

Having a close relationship with our customers is the only way we can fulfil our promise to add performance to your business.

More about us

Latest news

Monovet 90 received FDA approval making it the first FDA-approved generic monensin for use in beef, dairy and goat production in the USA.

Read more
Who we are

Huvepharma®’s focus: animal health and nutrition

Huvepharma® is a fast-growing global pharmaceutical company with a focus on developing, manufacturing and marketing human health and animal health and nutrition products. These pillars are the basis of our company name, Huvepharma: Human and Veterinary Pharmaceuticals.
more about us
news & insights

The latest news & insights

Article | 03.27.2020

Effect of Supplementing Phytase on Piglet Performance, Nutrient Digestibility and Bone Mineralisationn


Incremental levels of the phytase, OptiPhos® Plus, were fed to 150 weaned piglets (five treatments of 30 pigs) to determine the effect on piglet performance, nutrient digestibility and bone mineralisation. Piglets were fed a basal diet from four to six weeks and a pre-starter diet from six to ten weeks of age. The basal diets contained reduced digestible phosphorus (P) and calcium (Ca) (1.5 g/kg digestible P, and 5.5 g/kg and 5.6 g/kg Ca for weaner and pre-starter, respectively) to provide a negative control. Phytase was added a 0, 125, 250, 500 and 1,000 phytase units (FTU)/kg feed. Faecal samples were collected at nine weeks of age and analysed for P, Ca and crude protein (CP) content to calculated digestibility. Metacarpal bone IV mineralisation was assessed by ash content and the weight and length of the bone. Incremental increases of phytase improved final body weight (BW) (< 0.001), average daily gain (ADG) (p < 0.001) and feed conversion ratio (FCR) (< 0.01). The statistical model predicted a linear increase for daily feed intake (DFI), ADG and BW with increased phytase increments. BW at the end of the trial increased by 824 g per increase of 250 FTU/kg (< 0.001). ADG and DFI increased by 19 g/day (p < 0.001) and 18 g/day (p < 0.05) respectively, per increase of 250 FTU/kg. As the effect on ADG and final BW was higher at lowest doses, a quadratic effect for these parameters was observed, within the measured range of phytase levels (= 0.029 and 0.028, respectively). A reduction of 0.03 in FCR was observed for each 250 FTU/kg increase (< 0.01). For each increase of 250 FTU/kg, bone dry weight increased by 131 g (< 0.05) and bone ash concentration by 1.9% of fat free dry matter (< 0.001). The results showed that the addition of phytase to piglet diets low in P led to better utilisation of phytate-P and consequently better piglet performance.

Article | 03.25.2020

The Feed Additive that is Reducing Phosphorus Emissions

Article | 03.15.2020

Probiotics As A Tool To Support Optimal Production

Article | 03.09.2020

Are Probiotics Relevant in Modern Turkey Production?

Article | 02.24.2020

The First High-Tech Application Line in Central Europe

What we can do for you

Where we can help you

Great service

Our customers are at the centre of everything we do. We take pride in being responsive, efficient and competitive.

Global reach

Our extensive network of offices, affiliates and representatives cover over 90 countries, helping us reach every animal in the production chain.

High quality

We are committed to supplying only the highest quality products to our global customers, as certified by many national and international legislators.

Mindful of the environment

As we grow our brands, we also grow our global environmental consciousness while adding performance to your business.
Investing in innovation

Continued growth and improvement

At Huvepharma®, we understand that consistent growth is only achieved with a firm commitment to evolution and improvement. Ideas and suggestions for new partnerships, new products and new technologies are always welcome.
More about innovation
global presence

Local support from a global company

Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.
Find your local contact
about us


Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.
more about us

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region or click to see all products and services.




North America


South America

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.


United States

Click here to visit the local website or close this popup to stay on the global website.

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now

By continuing to view this website you agree to the Huvepharma® cookie statement. Read more Agree